Clinical Trial Update: β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing withdrawal of β-blockers in patients with heart failure with preserved ejection fraction and chronotropic incompetence to evaluate impac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronotropic Incompetence
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• β-blockers (beta-blockers)

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Heart Failure With Normal Ejection Fraction, Chronotropic Incompetence | Phase 4 | Status: COMPLETED